Serum Institute to invest 240 million pounds in UK, expand vaccine business
Serum Institute to invest 240 million pounds in UK, expand vaccine business
The Serum Institute of India will invest GBP 240 million in the UK to expand its vaccine business and set up a new sales office creating a large number of jobs, Downing Street has announced as part of plans for a GBP 1 billion India-UK Enhanced Trade Partnership.
advertisement
UPDATED: May 4, 2021 09:19 IST
The Serum Institute of India will invest GBP 240 million in the UK to expand its vaccine business. (Reuters)
The Serum Institute of India will invest GBP 240 million in the UK to expand its vaccine business and set up a new sales office creating a large number of jobs, Downing Street has announced as part of plans for a GBP 1 billion India-UK Enhanced Trade Partnership creating around 6,500 jobs in Britain. The Pune-based vaccine manufacturer is among a list of nearly 20 Indian companies across sectors such as healthcare, bio
Serum Institute to invest 240 million pounds in UK; leads cross-sector Indian investments
SECTIONS
Last Updated: May 04, 2021, 09:28 AM IST
Share
Synopsis
The Pune-based vaccine manufacturer is among a list of nearly 20 Indian companies across sectors such as healthcare, biotech and software services to announce significant investment plans in the UK.
Agencies
It was also revealed that the Serum Institute of India (SII) has started phase one trials in the UK of a nasal vaccine against coronavirus.
The Serum Institute of India will invest GBP 240 million in the UK to expand its vaccine business and set up a new sales office creating a large number of jobs, Downing Street has announced as part of plans for a GBP 1 billion India-UK Enhanced Trade Partnership creating around 6,500 jobs in Britain. The Pune-based vaccine manufacturer is among a list of nearly 20 Indian companies across sectors such as healthcare, biotech and software services to announce significant investment pla
London: The Serum Institute of India will invest GBP 240 million in the UK to expand its vaccine business and set up a new sales office creating a large
The UK and India will also look to discuss cooperation on climate, defense, health, and technology besides ramping up bilateral exports and investments.
Serum Institute of India leads cross-sector Indian investments into UK
LONDON, May 4: The Serum Institute of India will invest GBP 240 million in the UK to expand its vaccine business and set up a new sales office creating a large number of jobs, Downing Street has announced as part of plans for a GBP 1 billion India-UK Enhanced Trade Partnership creating around 6,500 jobs in Britain.
The Pune-based vaccine manufacturer is among a list of nearly 20 Indian companies across sectors such as healthcare, biotech and software services to announce significant investment plans in the UK.
It was also revealed that the Serum Institute of India (SII) has started phase one trials in the UK of a nasal vaccine against coronavirus.